title: Comparison of the pharmacokinetics of sulfamethoxazole in native Han and Tibetan male Chinese volunteers living at high altitude.
abstract: The aim of this study was to investigate the pharmacokinetics of sulfamethoxazole in native Han and Tibetan healthy Chinese subjects living chronically at high altitude. An open-labeled, controlled, prospective study was conducted in healthy Chinese male volunteers. Sulfamethoxazole 1,200 mg was administered orally to two groups: native Han and Tibetan volunteers living at high altitude (2,500-3,900 m [8,200-12,800 ft]). Blood samples were collected from an indwelling venous catheter into heparinized tubes before (baseline) study drug administration and at 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 36, and 48 h after study drug administration. Sulfamethoxazole in whole blood, plasma, and plasma water, and metabolite N (4)-acetyl-sulfamethoxazole in plasma were determined by HPLC. Tolerability was determined using blood chemistry testing, continuous 12-lead electrocardiogram, and blood pressure monitoring. The protein binding was significantly higher in the native Tibetan group (70.5 %) compared to the native Han group (67.3 %) (p < 0.05). The binding of sulfamethoxazole to red blood cells was 7.4 and 8.3 % in the native Han and native Tibetan groups, respectively. There was no significant difference between the two groups. The AUC(0-∞) was significantly lower in the native Tibetan group compared to the native Han group (p < 0.05), and other pharmacokinetics parameters were found to have no significant difference between the two groups. This study found little changes in the disposition of sulfamethoxazole in these native healthy Tibetan Chinese subjects living at high altitude in comparison to native healthy Han Chinese subjects living at high altitude.
authors.affiliation: Department of Pharmacy, Qinghai University Medical College, Xining, China. qhmclxy@163.com
authors.forename: Xiang-Yang
authors.initials: XY
authors.lastname: Li
authors.forename: Yong-Nian
authors.initials: YN
authors.lastname: Liu
authors.forename: Xue-Jun
authors.initials: XJ
authors.lastname: Wang
authors.forename: Jun-Bo
authors.initials: JB
authors.lastname: Zhu
authors.forename: Ming
authors.initials: M
authors.lastname: Yuan
authors.forename: Yong-Ping
authors.initials: YP
authors.lastname: Li
authors.forename: Yong-Fang
authors.initials: YF
authors.lastname: Li
mesh_terms: D000328:Adult; D000531:Altitude; D000890:Anti-Infective Agents / Q000493:pharmacokinetics*; D044466:Asian People; D001798:Blood Proteins / Q000378:metabolism; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011485:Protein Binding; D013420:Sulfamethoxazole / Q000493:pharmacokinetics; D018609:Tibet; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents; D001798:Blood Proteins; D013420:Sulfamethoxazole